Applications for products containing new active substances (new chemical entities) can be submitted to the EMEA for evaluation under the Centralised procedure or to the MHRA for a national marketing authorisation.
Applications for products containing new active substances (new chemical entities) can be submitted to the EMEA for evaluation under the Centralised procedure or to the MHRA for a national marketing authorisation.